Univasc (UCB, Inc.)
Welcome to the PulseAid listing for the Univasc drug offered from UCB, Inc.. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | UCB, Inc. |
| NON-PROPRIETARY NAME: | moexipril hydrochloride |
| SUBSTANCE NAME: | MOEXIPRIL HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1995-07-15 |
| END MARKETING DATE: | 0000-00-00 |
Univasc HUMAN PRESCRIPTION DRUG Details:
| Item Description | Univasc from UCB, Inc. |
| LABELER NAME: | UCB, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 7.5(mg/1) |
| START MARKETING DATE: | 1995-07-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0091-3707_2c711a79-fc80-331d-e054-00144ff88e88 |
| PRODUCT NDC: | 0091-3707 |
| APPLICATION NUMBER: | NDA020312 |
Other MOEXIPRIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
